Targeted physical activity for frail pancreatic cancer patients on neoadjuvant chemotherapy
Official title: Pilot Study Evaluating the Impact of Targeted Physical Activity Among Frail Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
Run by University of Illinois Chicago · NCT07647250 · Data updated 2026-11-12
This study tests a supervised, low‑intensity resistance exercise program to see if it helps frail or pre‑frail adults with pancreatic cancer who are receiving neoadjuvant chemotherapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | University of Illinois Chicago Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | June 22, 2026 |
| Main results expected | April 30, 2031 |
| Study ends | April 30, 2032 |
| Registry record updated | June 24, 2026 |
| Trial ID | NCT07647250 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with potentially resectable pancreatic cancer who are frail or pre‑frail and planned for or currently receiving neoadjuvant chemotherapy.
✕Probably not a fit
Patients who do not experience functional improvements or who cannot safely participate in supervised exercise may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates a 36‑session, twice‑weekly targeted physical exercise program delivered to frail or pre‑frail adults with potentially resectable pancreatic cancer undergoing neoadjuvant chemotherapy. The goal is to determine feasibility and safety of the program and to generate preliminary estimates of changes in functional outcomes. The study uses a supervised, individualized approach to improve strength and functional performance through resistance-based activities, with assessments planned to inform the design of a larger future trial. Eligibility requires adults 18 and older with pancreatic cancer planning or receiving neoadjuvant chemotherapy who meet predefined frailty criteria, and the ability to consent and complete assessments in English or Spanish. The lead sponsor is the University of Illinois Chicago, conducted at the University of Illinois Clinical Cancer Center in Chicago, IL.
Why it matters
Potential benefit: If successful, participants could experience improved physical function and tolerance to chemotherapy, potentially supporting better treatment continuity and surgical readiness.
How similar studies have gone: Previous work in similar cancer populations suggests targeted exercise can be feasible and may improve function, but this specific frailty‑focused, neoadjuvant pancreatic cancer program is a novel evaluation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years 2. Diagnosis of pancreatic cancer that is potentially resectable per the treating clinical team's assessment. 3. Planned to receive or actively receiving neoadjuvant chemotherapy prior to surgery. 4. Frail or pre-frail as defined by the protocol-specified frailty assessment tool (e.g., Fried Frailty Phenotype; pre-frail = 1-2 criteria; frail =\> 3 criteria). 5. Able to provide written informed consent. 6. Medically appropriate to participate in supervised, symptom-limited exercise as determined by study screening and, if indicated, the treating clinician's input. 7. Able to complete study assessments and questionnaires in English or Spanish (using IRB- approved instruments/materials). Exclusion Criteria: 1. Adults unable to consent. 2. Medical condition that, in the judgment of the investigator and/or treating clinician, makes exercise unsafe (e.g., unstable angina, uncontrolled arrhythmia, decompensated heart failure, uncontrolled severe pulmonary disease). 3. Any absolute contraindication to exercise participation/testing per institutional standards. 4. Severe symptoms or functional impairment that prevents safe participation despite program modification. 5. Inability to comply with the intervention schedule and study procedures despite reasonable scheduling accommodations.
Where it's running
-
University of Illinois Clinical Cancer Center
Chicago, Illinois, United States Recruiting
Study contacts
- Study coordinator: Aslam Ejaz, MD
- Email: aejaz@uic.edu
- Phone: 312 996 6666
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nurse-led programs mixing exercise and psychology to help people with chronic kidney disease
This study tests whether a nurse-led program that combines physical exercise and psychosocial support can improve outcomes for adults with chronic renal failure on dialysis or in hospital.
-
Supervised exercise after bariatric surgery to protect muscle and bone
This program tests whether supervised exercise after gastric bypass or sleeve surgery helps preserve muscle mass and bone density in adults.
-
Exercise plus oral nutrition to prevent disability in hospitalized adults 75 and older
We will test whether adding a supervised multicomponent exercise program to oral nutritional support helps hospitalized people aged 75 and older who are malnourished or at risk avoid disability and improve physical and cognitive function.
-
Exercise program for patients after atrial fibrillation ablation
This study is testing whether a structured exercise program can help people who had atrial fibrillation ablation feel better and improve their heart health and quality of life.
-
Radiofrequency and pelvic floor exercises for pelvic floor problems after breast cancer
This project will test whether radiofrequency, pelvic floor muscle exercises, or both can reduce pelvic floor and genitourinary symptoms in women who had breast cancer.
-
Effects of exercise training in lymphoma survivors
This study is testing whether adding aerobic and resistance exercise to usual care can improve fitness and health for people who have survived lymphoma.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.